Daunozer 20 mg

Daunozer 20 mg

Composition: Daunorubicin IP 20 mg

Therapeutic class: Anti-neoplastic

What is Daunozer?

It is a chemotherapy drug for various types of leukemia (blood cancers)

Uses of Daunozer

Acute leukemia (AML, ALL)

How does it work?

Daunorubicin inhibits DNA replication and division. It also generates free radicals that oxidize the cell membrane, causing cell death.

Common side effects

Low blood count

Hair loss

Mouth ulcers

Reddish colored urine

Weakness

High temperature

Loss of appetite

Serious side effects

Myloeuppresion

GIT bleeding

Hemorrhage

Cardio toxicity - irregular heartbeats, shortness of breath

Fluid retention

Liver toxicity

Painful urination

Precautions

It should be used cautiously in patients with -

Heart problems

Kidney diseases

Gout

Kidney stones

Liver diseases

Previous viral infection- chicken pox, shingles

Contraindications

Not to be used if any previous allergy or hypersensitivity to Daunorubicin or any excipients.

Breastfeeding mothers

Pregnant women

Warning

To be used under medical prescription only.

Safety and monitoring information

Monitor regularly-

Total blood count

Cardiac functions

Avoid leakage into surrounding tissues during infusion to prevent local necrosis.

Use effective contraception during the treatment and after the treatment for the recommended period.

Administration Instructions

To be administered intravenously only, as a slow IV infusion.

To be used immediately after reconstitution.

Storage

It should be stored at 2-8 degrees Celsius, protected from light.